EFGCP

@EFGCP

European Forum for Good Clinical Practice -- where science and ethics meet

Brussels
Vrijeme pridruživanja: rujan 2012.

Tweetovi

Blokirali ste korisnika/cu @EFGCP

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EFGCP

  1. Prikvačeni tweet
    17. sij

    🎓Join us for our 2 half-day GCP-Refresher trainings on Inspection Readiness and From Research Question to a GCP-conform Clinical Trial Protocol 👨‍🏫👩‍🏫👨‍🎓👩‍🎓 🗓️When: 10 February 2020 🏙️Where: Brussels Register her➡️ 🗒️More info here: ]

    Poništi
  2. prije 8 sati
    Poništi
  3. prije 12 sati

    BBC News - Artificial intelligence-created medicine to be used on humans for first time

    Poništi
  4. proslijedio/la je Tweet
    31. sij

    Why the industry is unlikely to be celebrating Brexit today on 31 January

    Poništi
  5. 31. sij

    R&D plans are the stars in new EU industrial strategy: A draft plan, for adoption in Brussels on 4 March, highlights the importance of research and innovation in making EU industry more competitive

    Poništi
  6. 30. sij

    EMA celebrates 25 years advancing public and animal health | European Medicines Agency via

    Poništi
  7. proslijedio/la je Tweet
    30. sij

    📅 As of today, Portuguese hospitals can access health data from Maltese citizens who are travelling to Portugal. Learn more about services here 👉

    Poništi
  8. proslijedio/la je Tweet
    30. sij

    Maggie De Block enjoint à Novartis d’abandonner sa «loterie de la vie» | Société

    Poništi
  9. 30. sij
    Poništi
  10. 30. sij

    AI-designed drug to enter human clinical trial for first time: Molecule designed by machine to treat OCD developed in just 12 months via

    Poništi
  11. proslijedio/la je Tweet
    29. sij

    's Oliver Bisazza explains why the solution to the notified body bottleneck already legally exists. But will the European Commission agree?

    Poništi
  12. proslijedio/la je Tweet
    29. sij

    Join 's 2 half-day GCP-Refresher trainings on Inspection Readiness and From Research Question to a GCP-conform Clinical Trial Protocol. When: 10th Feb 2020 Where: Brussels Register here: More info:

    Poništi
  13. 29. sij

    Are clinical trial participants a true representative of our population?

    Poništi
  14. 24. sij

    As many as 30% to 50% of chronic pain patients will respond to placebos: Some patients with chronic pain can get relief from a placebo even when they know it isn’t an active medication, a growing body of evidence shows: via

    Poništi
  15. proslijedio/la je Tweet
    23. sij
    Poništi
  16. proslijedio/la je Tweet
    23. sij
    , , i još njih 7
    Poništi
  17. 23. sij
    Poništi
  18. proslijedio/la je Tweet
    23. sij

    According to a new report by , the pipeline of new remains thin, partly due to low public investment, but also b/c companies retreated from antibiotics R&D when they saw sink ➡️

    , , i još njih 5
    Poništi
  19. 22. sij
    Poništi
  20. 21. sij
    Poništi
  21. proslijedio/la je Tweet
    21. sij

    New demands for companion diagnostics are high and having sufficient time to prepare for compliance is vital. But are delays threatening to cause delays for all IVDs?

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·